- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Progenics Pharmaceuticals Inc+ Add to Watchlist
PGNX:US7.2300 USD 0.1500 2.12%
As of 20:10:00 ET on 11/26/2014.
Company Profile for Progenics Pharmaceuticals Inc (PGNX)
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
Progenics Pharmaceuticals Inc
Key Executives for Progenics Pharmaceuticals Inc (PGNX)
|Mark Robert BakerChief Executive Officer||Robert J IsraelExec VP:Medical Affairs|
|Nitya G RaySenior VP:Manufacturing||Vivien WongSenior VP:Operations & Portfolio|
|Angelo W Lovallo JrVP:Finance/Treasurer||Ann Marie AssummaVP:Regulatory Affairs|
|Amy MartiniDirector:Corporate Affairs||David E MartinGeneral Counsel|